Safety and efficacy of low dose pioglitazone compared with standard dose pioglitazone in type 2 diabetes with chronic kidney disease: A randomized controlled trial

BACKGROUND: Choices of hypoglycemic agents for patients with type 2 diabetes and chronic kidney disease (CKD) are limited. Available data among patients with CKD suggest that pioglitazone was effective and safe, with no increase in serious adverse effects. However, weight gain and fluid retention ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Satirapoj, Bancha, Watanakijthavonkul, Khanin, Supasyndh, Ouppatham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209355/
https://www.ncbi.nlm.nih.gov/pubmed/30379936
http://dx.doi.org/10.1371/journal.pone.0206722

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209355/
https://www.ncbi.nlm.nih.gov/pubmed/30379936
http://dx.doi.org/10.1371/journal.pone.0206722

Ejemplares similares